Literature DB >> 15207926

Residual symptoms at remission from depression: impact on long-term outcome.

N Kennedy1, E S Paykel.   

Abstract

BACKGROUND: Although residual symptoms after remission from depression are common and predict early relapse, little is known about the impact of residual symptoms on longer-term clinical course of depression or social functioning.
METHODS: Sixty severe recurrent depressives, who remitted from an index episode of depression with residual symptoms or below residual symptomatology, were followed-up at 8-10 years. Subjects underwent detailed longitudinal interviewing on course of depression, treatment and socioecomonic functioning over follow-up.
RESULTS: Long-term follow-up data was obtained on all living subjects and 55 (95%) were interviewed. The residual symptoms group spent more time with depressive symptoms over follow-up but not at full criteria for major depression and showed greater impairment in longitudinal and follow-up social adjustment. No significant differences were found between the two groups in percentage recurring long-term, mean number of recurrences, readmissions, chronic episodes or clinical global outcome criteria. LIMITATIONS: Long-term clinical and social outcomes were assessed by a single retrospective longitudinal interview.
CONCLUSIONS: Patients who remit from depression with residual symptomatology continue to have more depressive symptoms and impaired social functioning long-term and may need more aggressive treatment. Copyright 2003 Elsevier B.V.

Entities:  

Mesh:

Year:  2004        PMID: 15207926     DOI: 10.1016/S0165-0327(03)00054-5

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  53 in total

1.  Calibration of response and remission cut-points on the Beck Depression Inventory-Second Edition for monitoring seasonal affective disorder treatment outcomes.

Authors:  Gloria M Reeves; Kelly J Rohan; Patricia Langenberg; Soren Snitker; Teodor T Postolache
Journal:  J Affect Disord       Date:  2012-01-25       Impact factor: 4.839

2.  Sensitivity to change and predictive validity of the MOODS-SR questionnaire, last-month version.

Authors:  Mario Miniati; Paola Rucci; Ellen Frank; Annalisa Oppo; David J Kupfer; Andrea Fagiolini; Giovanni B Cassano
Journal:  Psychother Psychosom       Date:  2009-02-13       Impact factor: 17.659

3.  Biological Age, Not Chronological Age, Is Associated with Late-Life Depression.

Authors:  Patrick J Brown; Melanie M Wall; Chen Chen; Morgan E Levine; Kristine Yaffe; Steven P Roose; Bret R Rutherford
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-09-11       Impact factor: 6.053

4.  Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.

Authors:  J E J Buckman; A Underwood; K Clarke; R Saunders; S D Hollon; P Fearon; S Pilling
Journal:  Clin Psychol Rev       Date:  2018-07-29

5.  Mindful mood balance: a case report of Web-based treatment of residual depressive symptoms.

Authors:  Jennifer Felder; Sona Dimidjian; Arne Beck; Jennifer M Boggs; Zindel Segal
Journal:  Perm J       Date:  2014-08-18

6.  Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.

Authors:  Shawn M McClintock; Mustafa M Husain; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Madhukar H Trivedi; Ian Cook; David Morris; Diane Warden; Augustus John Rush
Journal:  J Clin Psychopharmacol       Date:  2011-04       Impact factor: 3.153

Review 7.  Partial remission, residual symptoms, and relapse in depression.

Authors:  E S Paykel
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

8.  Four maternal characteristics determine the 12-month course of chronic severe postpartum depressive symptoms.

Authors:  Sheehan D Fisher; Dorothy K Sit; Amy Yang; Jody D Ciolino; Jackie K Gollan; Katherine L Wisner
Journal:  Depress Anxiety       Date:  2019-01-15       Impact factor: 6.505

9.  Expectancy and the Treatment of Depression: A Review of Experimental Methodology and Effects on Patient Outcome.

Authors:  Bret R Rutherford; Tor D Wager; Steven P Roose
Journal:  Curr Psychiatry Rev       Date:  2010-02-01

10.  Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials.

Authors:  Bret R Rutherford; Melanie M Wall; Patrick J Brown; Tse-Hwei Choo; Tor D Wager; Bradley S Peterson; Sarah Chung; Irving Kirsch; Steven P Roose
Journal:  Am J Psychiatry       Date:  2016-09-09       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.